Robin Feldman

Feldman’s work focuses on the role of intellectual property law in technology and innovation, drug pricing and health care, and artificial intelligence and data.

She has published four books: Drugs, Money, & Secret Handshakes; Drug Wars, Rethinking Patent Law, and The Role of Science in Law. She has published more than 50 articles in law journals, including Harvard, Yale, and Stanford, in The New England Journal of Medicine, and in American Economic Review. Her op-eds have appeared in the New York Times, Washington Post, Boston Globe, The Hill, and others.

Feldman has been cited extensively by the White House, federal and state agencies, and members of Congress. Both sides of a recent Supreme Court case cited her IP/Antitrust work. She has appeared frequently before committees of the US House & Senate, Cal. legislature, and federal agencies such as the FTC, DOJ, and USPTO. She participated in the GAO’s AI report to Congress and the Army Cyber Institute’s weaponization of data exercise.